Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose methotrexate followed by etoposide/cytarabine with stem cell support and temozolomide maintenance for newly diagnosed primary CNS B-cell lymphoma
ChiCTR-OPN-15006417Phase 4Not yet recruiting
- Sponsor
- Department of Hematology, Peking Union Medical College Hospital
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methotrexate, etoposide, cytarabine and temozolomide in primary central nervous system lymphoma (PCNSL), sponsored by Department of Hematology, Peking Union Medical College Hospital. Primary endpoint: Overall response rate. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
methotrexateetoposidecytarabinetemozolomide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on ChiCTR-OPN-15006417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006417.